{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:02:11Z","timestamp":1788498131645,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":3144,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1074\/jbc.m111.308668","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T02:27:17Z","timestamp":1323224837000},"page":"4107-4120","source":"Crossref","is-referenced-by-count":73,"title":["Different 8-Hydroxyquinolines Protect Models of TDP-43 Protein, \u03b1-Synuclein, and Polyglutamine Proteotoxicity through Distinct Mechanisms"],"prefix":"10.1016","volume":"287","author":[{"given":"Daniel F.","family":"Tardiff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy A.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M111.308668_bib1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","article-title":"\u03b1-Synuclein and neurodegenerative diseases","volume":"2","author":"Goedert","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1074\/jbc.M111.308668_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","article-title":"Soluble oligomers of the amyloid \u03b2-protein impair synaptic plasticity and behavior","volume":"192","author":"Selkoe","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1074\/jbc.M111.308668_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrneurol.2010.18","article-title":"TAR DNA-binding protein 43 in neurodegenerative disease","volume":"6","author":"Chen-Plotkin","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1074\/jbc.M111.308668_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nrn2809","article-title":"Modeling neurodegeneration in Saccharomyces cerevisiae. Why cook with baker's yeast?","volume":"11","author":"Khurana","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1074\/jbc.M111.308668_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","article-title":"\u03b1-Synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models","volume":"313","author":"Cooper","year":"2006","journal-title":"Science"},{"key":"10.1074\/jbc.M111.308668_bib6","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.1090439","article-title":"Yeast cells provide insight into \u03b1-synuclein biology and pathobiology","volume":"302","author":"Outeiro","year":"2003","journal-title":"Science"},{"key":"10.1074\/jbc.M111.308668_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1242\/dmm.004267","article-title":"Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models","volume":"3","author":"Su","year":"2010","journal-title":"Dis. Model Mech."},{"key":"10.1074\/jbc.M111.308668_bib8","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1091\/mbc.e09-09-0801","article-title":"\u03b1-Synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER\/Golgi SNAREs","volume":"21","author":"Thayanidhi","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.M111.308668_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1073\/pnas.0710685105","article-title":"The Parkinson's disease protein \u03b1-synuclein disrupts cellular Rab homeostasis","volume":"105","author":"Gitler","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.308668_bib10","doi-asserted-by":"crossref","first-page":"e1000027","DOI":"10.1371\/journal.pgen.1000027","article-title":"C. elegans model identifies genetic modifiers of \u03b1-synuclein inclusion formation during aging","volume":"4","author":"van Ham","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1074\/jbc.M111.308668_bib11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ng.300","article-title":"\u03b1-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity","volume":"41","author":"Gitler","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M111.308668_bib12","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M111.308668_bib13","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1073\/pnas.97.4.1589","article-title":"Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins","volume":"97","author":"Krobitsch","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.308668_bib14","doi-asserted-by":"crossref","first-page":"11045","DOI":"10.1073\/pnas.0604547103","article-title":"Flanking sequences profoundly alter polyglutamine toxicity in yeast","volume":"103","author":"Duennwald","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.308668_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","article-title":"Trinucleotide repeat disorders","volume":"30","author":"Orr","year":"2007","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1074\/jbc.M111.308668_bib16","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1101\/gad.1673408","article-title":"Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity","volume":"22","author":"Duennwald","year":"2008","journal-title":"Genes Dev."},{"key":"10.1074\/jbc.M111.308668_bib17","doi-asserted-by":"crossref","first-page":"11051","DOI":"10.1073\/pnas.0604548103","article-title":"A network of protein interactions determines polyglutamine toxicity","volume":"103","author":"Duennwald","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.308668_bib18","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1073\/pnas.0802082105","article-title":"A yeast TDP-43 proteinopathy model. Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity","volume":"105","author":"Johnson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.308668_bib19","doi-asserted-by":"crossref","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","article-title":"TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity","volume":"284","author":"Johnson","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.308668_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1074\/jbc.M111.308668_bib21","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"10.1074\/jbc.M111.308668_bib22","doi-asserted-by":"crossref","first-page":"e1000193","DOI":"10.1371\/journal.pgen.1000193","article-title":"Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis","volume":"4","author":"Rutherford","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1074\/jbc.M111.308668_bib23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4161\/rna.7.4.12205","article-title":"The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation","volume":"7","author":"Buratti","year":"2010","journal-title":"RNA Biol."},{"key":"10.1074\/jbc.M111.308668_bib24","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1242\/jcs.051672","article-title":"Prion-like disorders. Blurring the divide between transmissibility and infectivity","volume":"123","author":"Cushman","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1074\/jbc.M111.308668_bib25","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"key":"10.1074\/jbc.M111.308668_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s12031-011-9548-9","article-title":"Model organisms reveal insight into human neurodegenerative disease. Ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS","volume":"45","author":"Bonini","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1074\/jbc.M111.308668_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1073\/pnas.0307490100","article-title":"Chemogenomic profiling. Identifying the functional interactions of small molecules in yeast","volume":"101","author":"Giaever","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.308668_bib28","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1101\/gr.6037607","article-title":"Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae","volume":"17","author":"Hu","year":"2007","journal-title":"Genome Res."},{"key":"10.1074\/jbc.M111.308668_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial A\u03b2","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"key":"10.1074\/jbc.M111.308668_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a copper-zinc chelator markedly and rapidly inhibits \u03b2-amyloid accumulation in Alzheimer's disease transgenic mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"key":"10.1074\/jbc.M111.308668_bib31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2 in targeting A\u03b2 as a modifying therapy for Alzheimer's disease. A phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1074\/jbc.M111.308668_bib32","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo. A novel therapy for Parkinson's disease","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"key":"10.1074\/jbc.M111.308668_bib33","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1073\/pnas.0502177102","article-title":"Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model","volume":"102","author":"Nguyen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.308668_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-2010-1390","article-title":"PBT2 rapidly improves cognition in Alzheimer's disease. Additional phase II analyses","volume":"20","author":"Faux","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1074\/jbc.M111.308668_bib35","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/hmg\/ddq230","article-title":"Neurotoxic effects of TDP-43 overexpression in C. elegans","volume":"19","author":"Ash","year":"2010","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.M111.308668_bib36","doi-asserted-by":"crossref","first-page":"16208","DOI":"10.1523\/JNEUROSCI.2911-10.2010","article-title":"Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy","volume":"30","author":"Liachko","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1074\/jbc.M111.308668_bib37","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1021\/bi0272151","article-title":"Metal binding and oxidation of amyloid-\u03b2 within isolated senile plaque cores. Raman microscopic evidence","volume":"42","author":"Dong","year":"2003","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M111.308668_bib38","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","article-title":"Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1074\/jbc.M111.308668_bib39","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3233\/JAD-2010-100024","article-title":"The metal chelating and chaperoning effects of clioquinol. Insights from yeast studies","volume":"21","author":"Li","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1074\/jbc.M111.308668_bib40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00775-008-0404-5","article-title":"Metal ions in biological catalysis. From enzyme databases to general principles","volume":"13","author":"Andreini","year":"2008","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1074\/jbc.M111.308668_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1023\/A:1020771000746","article-title":"Yeast, a model organism for iron and copper metabolism studies","volume":"16","author":"De Freitas","year":"2003","journal-title":"Biometals"},{"key":"10.1074\/jbc.M111.308668_bib42","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nature08300","article-title":"Metalloproteins and metal sensing","volume":"460","author":"Waldron","year":"2009","journal-title":"Nature"},{"key":"10.1074\/jbc.M111.308668_bib43","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1074\/jbc.M807579200","article-title":"The anti-neurodegeneration drug clioquinol inhibits the aging-associated protein CLK-1","volume":"284","author":"Wang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.308668_bib44","doi-asserted-by":"crossref","first-page":"e15535","DOI":"10.1371\/journal.pone.0015535","article-title":"Quantitative high throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors","volume":"5","author":"King","year":"2010","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M111.308668_bib45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000065696","article-title":"Iron, a pathological mediator of Alzheimer disease?","volume":"24","author":"Bishop","year":"2002","journal-title":"Dev. Neurosci."},{"key":"10.1074\/jbc.M111.308668_bib46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JAD-2006-102-303","article-title":"Metals and Alzheimer's disease","volume":"10","author":"Adlard","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1074\/jbc.M111.308668_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-510X(96)00203-1","article-title":"Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease. Possible relation to oxidative stress","volume":"143","author":"Deibel","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1074\/jbc.M111.308668_bib48","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.8073293","article-title":"Rapid induction of Alzheimer A \u03b2 amyloid formation by zinc","volume":"265","author":"Bush","year":"1994","journal-title":"Science"},{"key":"10.1074\/jbc.M111.308668_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.arr.2004.01.003","article-title":"Does cellular iron dysregulation play a causative role in Parkinson's disease","volume":"3","author":"Kaur","year":"2004","journal-title":"Ageing Res. Rev."},{"key":"10.1074\/jbc.M111.308668_bib50","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1371\/journal.pone.0000334","article-title":"Mechanisms of copper ion mediated Huntington's disease progression","volume":"2","author":"Fox","year":"2007","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M111.308668_bib51","first-page":"147","article-title":"TDP-43 in aging and Alzheimer's disease. A review","volume":"4","author":"Wilson","year":"2011","journal-title":"Int. J. Clin. Exp. Pathol"},{"key":"10.1074\/jbc.M111.308668_bib52","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","article-title":"Co-morbidity of TDP-43 proteinopathy in Lewy Body related diseases","volume":"114","author":"Nakashima-Yasuda","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1074\/jbc.M111.308668_bib53","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","article-title":"Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease","volume":"67","author":"Schwab","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1074\/jbc.M111.308668_bib54","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00702-004-0143-x","article-title":"Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases","volume":"111","author":"Youdim","year":"2004","journal-title":"J. Neural Transm."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820482171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820482171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M111.308668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T17:11:15Z","timestamp":1641316275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820482171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0021925820482171"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m111.308668","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}